MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion

Ilan Elson-Schwab, Anna Lorentzen, Christopher J Marshall, Ilan Elson-Schwab, Anna Lorentzen, Christopher J Marshall

Abstract

Background: A functional role of microRNAs (miRNAs or miRs) in neoplasia and metastasis is becoming clear, and the miR-200 family has received much attention for potentially regulating tumor progression. The miRNAs of this family have been shown to suppress epithelial-mesenchymal transition, and their down-regulation in some tumors promotes invasion and metastasis. Interestingly, while miR-200 is down-regulated in some cancers, it is up-regulated in others.

Principal findings: We show that levels of miR-200 are increased in melanoma cell lines compared to normal melanocytes and that miR-200 family members play a role in determining modes of tumor cell migration. Individual tumor cells can invade in either elongated, "mesenchymal-type" or rounded, "amoeboid-like" modes and these two modes of invasion are inter-convertible [1]. In melanoma cell lines, expression of miR-200 members does not suppress invasion but rather leads to a switch between modes of invasion. MicroRNA-200c results in a higher proportion of cells adopting the rounded, amoeboid-like mode of invasion, while miR-200a results in a protrusion-associated elongated mode of invasion. Functional target identification studies suggest that the morphological effects of miR-200c may be mediated by reduced expression of MARCKS, which has been linked to formation of cell protrusions. In contrast miR-200a reduces actomyosin contractility, a feature of rounded morphology.

Significance: Overall our findings call into question the general role of miR-200 in suppressing invasion and metastasis, and highlight novel distinguishing characteristics of individual miR-200 family members.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. microRNA-200 regulates morphological plasticity of…
Figure 1. microRNA-200 regulates morphological plasticity of melanoma cells.
(A) Schematic representation of the miR-200 family. (B) Relative levels of expression of miR-200a and -200c, normalized to the invariant miR-30b*, in melanoma cell lines compared to normal human epidermal melanocytes. (C) Transfection of miR-200a in Wm266.4 results in an elongated morphology of cells invading into collagen, while miR-200c transfection results in a rounded morphology (scale bars in um). Quantification of the percentage of cells with rounded morphology for melanoma cell lines invading into collagen. (D) miR-200 family members do not inhibit melanoma cell invasion, but can promote invasion. Each experiment was performed at least three times and representative examples are shown. Error bars represent ± SEM; unpaired t-test *p

Figure 2. microRNA-200c regulates MARCKS.

(A) The…

Figure 2. microRNA-200c regulates MARCKS.

(A) The effect of miR-200c transfection on mRNA levels of…

Figure 2. microRNA-200c regulates MARCKS.
(A) The effect of miR-200c transfection on mRNA levels of predicted target genes in Wm266.4 melanoma cells was assessed using GAPDH as a control. Lower panel: immunoblot of MARCKS expression. (B) Brightfield imaging and morphological quantification of Wm266.4 cells transfected with siRNAs targeting miR-200c-responsive genes. (C) MARCKS knock-down by four individual siRNAs leads to rounded cell shape in Wm266.4 cells. (D) Levels of MARCKS mRNA in melanoma cell lines and normal melanocytes, measured by qPCR and normalized to levels of GAPDH. Error bars represent ± SEM; unpaired t-test *p

Figure 3. MARCKS expression leads to protrusion…

Figure 3. MARCKS expression leads to protrusion formation in melanoma cells.

Images of GFP-MARCKS or…

Figure 3. MARCKS expression leads to protrusion formation in melanoma cells.
Images of GFP-MARCKS or GFP expressing Wm266.4 cells plated on a thick layer of collagen-I. Error bars represent ± SEM; unpaired t-test **p

Figure 4. miR-200a associated elongation is associated…

Figure 4. miR-200a associated elongation is associated with decreased actomyosin contractility.

(A) The effect of…

Figure 4. miR-200a associated elongation is associated with decreased actomyosin contractility.
(A) The effect of miR-200a transfection on mRNA levels was measured for predicted target genes in Wm266.4 melanoma cells using GAPDH as a control. (B) Transfection of Wm266.4 cells with miR-200a leads to decreased pMLC levels.
Similar articles
Cited by
References
    1. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell. 2008;135:510–523. - PubMed
    1. Fidler IJ. Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother Pharmacol. 1999;43(Suppl):S3–10. - PubMed
    1. Sahai E, Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol. 2003;5:711–719. - PubMed
    1. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol. 2003;160:267–277. - PMC - PubMed
    1. Hurteau GJ, Carlson JA, Spivack SD, Brock GJ. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 2007;67:7972–7976. - PubMed
Show all 44 references
Publication types
MeSH terms
Substances
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 2. microRNA-200c regulates MARCKS.
Figure 2. microRNA-200c regulates MARCKS.
(A) The effect of miR-200c transfection on mRNA levels of predicted target genes in Wm266.4 melanoma cells was assessed using GAPDH as a control. Lower panel: immunoblot of MARCKS expression. (B) Brightfield imaging and morphological quantification of Wm266.4 cells transfected with siRNAs targeting miR-200c-responsive genes. (C) MARCKS knock-down by four individual siRNAs leads to rounded cell shape in Wm266.4 cells. (D) Levels of MARCKS mRNA in melanoma cell lines and normal melanocytes, measured by qPCR and normalized to levels of GAPDH. Error bars represent ± SEM; unpaired t-test *p

Figure 3. MARCKS expression leads to protrusion…

Figure 3. MARCKS expression leads to protrusion formation in melanoma cells.

Images of GFP-MARCKS or…

Figure 3. MARCKS expression leads to protrusion formation in melanoma cells.
Images of GFP-MARCKS or GFP expressing Wm266.4 cells plated on a thick layer of collagen-I. Error bars represent ± SEM; unpaired t-test **p

Figure 4. miR-200a associated elongation is associated…

Figure 4. miR-200a associated elongation is associated with decreased actomyosin contractility.

(A) The effect of…

Figure 4. miR-200a associated elongation is associated with decreased actomyosin contractility.
(A) The effect of miR-200a transfection on mRNA levels was measured for predicted target genes in Wm266.4 melanoma cells using GAPDH as a control. (B) Transfection of Wm266.4 cells with miR-200a leads to decreased pMLC levels.
Similar articles
Cited by
References
    1. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell. 2008;135:510–523. - PubMed
    1. Fidler IJ. Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother Pharmacol. 1999;43(Suppl):S3–10. - PubMed
    1. Sahai E, Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol. 2003;5:711–719. - PubMed
    1. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol. 2003;160:267–277. - PMC - PubMed
    1. Hurteau GJ, Carlson JA, Spivack SD, Brock GJ. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 2007;67:7972–7976. - PubMed
Show all 44 references
Publication types
MeSH terms
Substances
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 3. MARCKS expression leads to protrusion…
Figure 3. MARCKS expression leads to protrusion formation in melanoma cells.
Images of GFP-MARCKS or GFP expressing Wm266.4 cells plated on a thick layer of collagen-I. Error bars represent ± SEM; unpaired t-test **p

Figure 4. miR-200a associated elongation is associated…

Figure 4. miR-200a associated elongation is associated with decreased actomyosin contractility.

(A) The effect of…

Figure 4. miR-200a associated elongation is associated with decreased actomyosin contractility.
(A) The effect of miR-200a transfection on mRNA levels was measured for predicted target genes in Wm266.4 melanoma cells using GAPDH as a control. (B) Transfection of Wm266.4 cells with miR-200a leads to decreased pMLC levels.
Figure 4. miR-200a associated elongation is associated…
Figure 4. miR-200a associated elongation is associated with decreased actomyosin contractility.
(A) The effect of miR-200a transfection on mRNA levels was measured for predicted target genes in Wm266.4 melanoma cells using GAPDH as a control. (B) Transfection of Wm266.4 cells with miR-200a leads to decreased pMLC levels.

References

    1. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell. 2008;135:510–523.
    1. Fidler IJ. Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother Pharmacol. 1999;43(Suppl):S3–10.
    1. Sahai E, Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol. 2003;5:711–719.
    1. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol. 2003;160:267–277.
    1. Hurteau GJ, Carlson JA, Spivack SD, Brock GJ. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 2007;67:7972–7976.
    1. Sossey-Alaoui K, Bialkowska K, Plow EF. The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion. J Biol Chem. 2009;284:33019–33029.
    1. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008;451:147–152.
    1. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15–20.
    1. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008;9:582–589.
    1. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10:593–601.
    1. Korpal M, Lee ES, Hu G, Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008;283:14910–14914.
    1. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008;22:894–907.
    1. Hurteau GJ, Carlson JA, Roos E, Brock GJ. Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression. Cell Cycle. 2009;8:2064–2069.
    1. Mueller DW, Rehli M, Bosserhoff AK. miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol. 2009;129:1740–1751.
    1. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26:462–469.
    1. Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res. 2008;18:549–557.
    1. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, et al. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007;67:8699–8707.
    1. Xi Y, Formentini A, Chien M, Weir DB, Russo JJ, et al. Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights. 2006;2:113–121.
    1. Pinner S, Sahai E. PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE. Nat Cell Biol. 2008;10:127–137.
    1. Uhlmann S, Zhang JD, Schwager A, Mannsperger H, Riazalhosseini Y, et al. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene. 2010;29:4297–4306.
    1. Smith HW, Marra P, Marshall CJ. uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180. J Cell Biol. 2008;182:777–790.
    1. Cochrane DR, Spoelstra NS, Howe EN, Nordeen SK, Richer JK. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol Cancer Ther. 2009.
    1. Hurteau GJ, Spivack SD, Brock GJ. Potential mRNA degradation targets of hsa-miR-200c, identified using informatics and qRT-PCR. Cell Cycle. 2006;5:1951–1956.
    1. Nielsen CB, Shomron N, Sandberg R, Hornstein E, Kitzman J, et al. Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. RNA. 2007;13:1894–1910.
    1. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, et al. The impact of microRNAs on protein output. Nature. 2008;455:64–71.
    1. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, et al. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455:58–63.
    1. Estrada-Bernal A, Gatlin JC, Sunpaweravong S, Pfenninger KH. Dynamic adhesions and MARCKS in melanoma cells. J Cell Sci. 2009;122:2300–2310.
    1. Wilkinson S, Paterson HF, Marshall CJ. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. Nat Cell Biol. 2005;7:255–261.
    1. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, et al. Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res. 2008;14:2535–2542.
    1. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology. 2006;130:2113–2129.
    1. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513–10518.
    1. Kent OA, Mullendore M, Wentzel EA, Lopez-Romero P, Tan AC, et al. A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells. Cancer Biol Ther. 2009;8:2013–2024.
    1. Mees ST, Mardin WA, Wendel C, Baeumer N, Willscher E, et al. EP300–a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int J Cancer. 2010;126:114–124.
    1. Pogribny IP, Muskhelishvili L, Tryndyak VP, Beland FA. The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol Appl Pharmacol. 2009;235:305–311.
    1. Zhang L, Deng T, Li X, Liu H, Zhou H, et al. microRNA-141 is involved in a nasopharyngeal carcinoma related genes network. Carcinogenesis. 2010.
    1. Hyun S, Lee JH, Jin H, Nam J, Namkoong B, et al. Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K. Cell. 2009;139:1096–1108.
    1. Dykxhoorn DM, Wu Y, Xie H, Yu F, Lal A, et al. miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One. 2009;4:e7181.
    1. Thelen M, Rosen A, Nairn AC, Aderem A. Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane. Nature. 1991;351:320–322.
    1. Calabrese B, Halpain S. Essential role for the PKC target MARCKS in maintaining dendritic spine morphology. Neuron. 2005;48:77–90.
    1. Michel S, Kloor M, Singh S, Gdynia G, Roth W, et al. Coding microsatellite instability analysis in microsatellite unstable small intestinal adenocarcinomas identifies MARCKS as a common target of inactivation. Mol Carcinog. 2010;49:175–182.
    1. Joseph CK, Qureshi SA, Wallace DJ, Foster DA. MARCKS protein is transcriptionally down-regulated in v-Src-transformed BALB/c 3T3 cells. J Biol Chem. 1992;267:1327–1330.
    1. Manenti S, Malecaze F, Chap H, Darbon JM. Overexpression of the myristoylated alanine-rich C kinase substrate in human choroidal melanoma cells affects cell proliferation. Cancer Res. 1998;58:1429–1434.
    1. Li T, Li D, Sha J, Sun P, Huang Y. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun. 2009;383:280–285.
    1. Gadea G, Sanz-Moreno V, Self A, Godi A, Marshall CJ. DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells. Curr Biol. 2008;18:1456–1465.

Source: PubMed

3
Subscribe